Cancer Death Rates Drop Significantly as New Treatments Emerge

There is encouraging news in the fight against cancer. According to the American Association for Cancer Research's annual Cancer Progress Report, the cancer death rate has dropped by 35% among children and 25% among adults between 1991 and 2014. This significant decline in cancer deaths is a testament to advancements in cancer research and treatment.

More innovative cancer treatments are on the horizon, offering further hope for reducing cancer deaths. The FDA has recently approved nine new cancer therapies and expanded the approved uses of eight existing treatments to fight different types of cancer. These new treatments include:

Immunotherapy: Harnessing the Power of the Immune System

Immunotherapy is a groundbreaking approach that helps a patient's own immune system fight cancer. These new FDA-approved immunotherapies have shown promise in helping some cancer patients live longer with an improved quality of life.

Imaging Agents: Enhancing Precision in Cancer Surgery

A newly approved imaging agent will enable surgeons to more precisely remove brain tumors. By improving the accuracy of cancer surgery, this advancement can lead to better outcomes and reduced complications for patients.

Targeted Therapy: Attacking Cancer at the Molecular Level

Targeted therapy involves drugs or substances that specifically target molecules responsible for the growth and spread of cancer. By attacking cancer cells more precisely, targeted therapy can be more effective and cause fewer side effects compared to traditional chemotherapy.

The Future of Cancer Treatment

With these new FDA-approved treatments and continued advancements in cancer research, there is renewed hope for further reducing cancer deaths in the years to come. As our understanding of cancer biology improves and more targeted, personalized therapies are developed, we can expect to see even more progress in the fight against this devastating disease.

For more information on the latest advancements in cancer research and treatment, visit the National Cancer Institute and the American Society of Clinical Oncology websites.